[Cefotetan treatment of suppurative bronchopulmonary syndromes sustained by anaerobic germs]

Arch Monaldi Mal Torace. 1990 Sep-Oct;45(5):401-10.
[Article in Italian]

Abstract

The Authors have analyzed the effect of Cefotetan in 20 patients affected by bronchopulmonary pathologies supported by anaerobic bacterium. During 7 days doses of 50 mg. pro Kg/pro die were given. From beginning to end of the treatment clinical, hematochemical and radiological data were evaluated. Bacteriological analysis was made on samples drawn with BFS according to a traditional method and with microbiology specimen brush. Almost all the patients (95%) realized improvements in clinical symptomatology and in radiological picture.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Bacteria, Anaerobic* / drug effects
  • Bacteria, Anaerobic* / isolation & purification
  • Bacterial Infections / drug therapy*
  • Bacterial Infections / microbiology
  • Bacteriological Techniques / instrumentation
  • Bronchiectasis / drug therapy*
  • Bronchiectasis / microbiology
  • Cefotetan / pharmacology
  • Cefotetan / therapeutic use*
  • Child
  • Female
  • Humans
  • Lung Abscess / drug therapy*
  • Lung Abscess / microbiology
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Respiratory Tract Infections / drug therapy*
  • Respiratory Tract Infections / microbiology

Substances

  • Cefotetan